BEPANTHEN

Main information

  • Trade name:
  • BEPANTHEN 100 mg lozenge
  • Dosage:
  • 100 mg
  • Pharmaceutical form:
  • lozenge
  • Prescription type:
  • No Prescription (OTC)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • BEPANTHEN 100 mg lozenge
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Dexpanthenol

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 860
  • Authorization date:
  • 19-04-2006
  • Last update:
  • 26-07-2018